Share Facebook Twitter LinkedIn Pinterest Email Gossamer Bio downgraded by Cantor on unclear regulatory path for seralutinib
World Acceptance Non-GAAP EPS of $2.12 beats by $1.54, revenue of $139.21M misses by $4.69MJuly 24, 2026